MASSI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 31.000
EU - Europa 22.855
AS - Asia 14.548
SA - Sud America 1.902
AF - Africa 474
OC - Oceania 343
Continente sconosciuto - Info sul continente non disponibili 12
Totale 71.134
Nazione #
US - Stati Uniti d'America 30.547
RU - Federazione Russa 6.371
IT - Italia 4.875
PL - Polonia 4.788
SG - Singapore 4.127
CN - Cina 3.394
HK - Hong Kong 2.081
IE - Irlanda 1.574
BR - Brasile 1.483
VN - Vietnam 1.445
KR - Corea 1.247
SE - Svezia 1.243
DE - Germania 855
FI - Finlandia 690
UA - Ucraina 681
FR - Francia 664
GB - Regno Unito 550
IN - India 536
AU - Australia 336
BD - Bangladesh 318
CA - Canada 274
JO - Giordania 215
TR - Turchia 209
ID - Indonesia 202
JP - Giappone 160
AR - Argentina 155
NL - Olanda 147
CH - Svizzera 106
IQ - Iraq 96
ES - Italia 90
MX - Messico 84
CI - Costa d'Avorio 77
EC - Ecuador 73
ZA - Sudafrica 72
MA - Marocco 70
NG - Nigeria 68
PH - Filippine 60
PK - Pakistan 53
MY - Malesia 51
TH - Thailandia 45
CO - Colombia 44
IR - Iran 39
CL - Cile 38
BE - Belgio 36
TW - Taiwan 34
VE - Venezuela 34
KE - Kenya 31
UZ - Uzbekistan 31
EG - Egitto 30
SA - Arabia Saudita 30
AT - Austria 29
PE - Perù 25
DZ - Algeria 24
PY - Paraguay 23
AE - Emirati Arabi Uniti 21
BJ - Benin 21
NP - Nepal 21
KZ - Kazakistan 20
RO - Romania 19
AZ - Azerbaigian 17
JM - Giamaica 16
AL - Albania 15
SC - Seychelles 15
TN - Tunisia 15
TZ - Tanzania 15
CR - Costa Rica 14
DK - Danimarca 14
LT - Lituania 14
OM - Oman 14
IL - Israele 13
CZ - Repubblica Ceca 12
DO - Repubblica Dominicana 12
UY - Uruguay 12
BO - Bolivia 11
BH - Bahrain 10
NI - Nicaragua 10
UG - Uganda 10
KW - Kuwait 9
NO - Norvegia 9
PT - Portogallo 9
BA - Bosnia-Erzegovina 8
BG - Bulgaria 8
EU - Europa 8
GR - Grecia 8
HN - Honduras 8
CY - Cipro 7
KG - Kirghizistan 7
NZ - Nuova Zelanda 7
PA - Panama 7
PR - Porto Rico 7
SN - Senegal 6
GE - Georgia 5
MT - Malta 5
TL - Timor Orientale 5
TT - Trinidad e Tobago 5
BY - Bielorussia 4
GY - Guiana 4
HR - Croazia 4
HU - Ungheria 4
LV - Lettonia 4
Totale 71.049
Città #
Santa Clara 5.083
Warsaw 4.773
Ashburn 3.504
Singapore 2.913
Fairfield 2.861
Hong Kong 1.691
Dublin 1.567
Chandler 1.517
Woodbridge 1.352
Seattle 1.238
Seoul 1.216
Cambridge 1.177
Houston 1.121
Jacksonville 1.098
Wilmington 1.010
Milan 910
San Jose 882
Hefei 843
Beijing 612
Lawrence 502
Ann Arbor 491
Altamura 489
Ho Chi Minh City 459
The Dalles 443
Los Angeles 440
Princeton 428
Rome 425
Lauterbourg 399
Buffalo 391
Council Bluffs 383
Hanoi 318
Florence 316
Melbourne 308
Boston 298
Boardman 277
Moscow 270
Mumbai 269
Helsinki 254
New York 249
Medford 202
Dallas 197
Munich 182
San Diego 176
Jakarta 136
Tokyo 133
Shanghai 128
Naples 126
Kent 121
Izmir 119
São Paulo 113
Paris 109
Turin 106
Bern 98
Frankfurt am Main 85
Norwalk 82
Bologna 80
Chicago 79
Dong Ket 78
Abidjan 77
West Jordan 76
Turku 75
Clifton 71
Toronto 71
Redondo Beach 70
Bremen 66
London 66
Orem 64
Haiphong 63
Phoenix 63
Da Nang 62
Abuja 59
Chennai 59
Venice 56
Montreal 55
Miano 53
Verona 53
Figino 52
Genoa 50
Barcelona 48
Palermo 48
Rio de Janeiro 48
Hillsboro 46
Bengaluru 44
Bari 43
Brescia 42
Falls Church 42
Guangzhou 42
Lappeenranta 42
Brooklyn 41
Yubileyny 40
Tianjin 38
Curitiba 36
Manchester 36
Atlanta 35
Baghdad 34
Andover 33
Johannesburg 33
Auburn Hills 32
Pune 32
Stockholm 32
Totale 47.255
Nome #
Formalin safety in anatomic pathology workflow and integrated air monitoring systems for the formaldehyde occupational exposure assessment 805
"Tuscany Registry for sAdden Cardiac DEath": metodo per la creazione di un registro multicentrico per la gestione di eventi di morte improvvisa in età giovanile 487
PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics. 395
Atypical CD30+ cutaneous lymphoid proliferation in a patient with tuberculosis infection. 340
Droplet digital PCR (ddPCR) vs quantitative real-time PCR (qPCR) approach for detection and quantification of Merkel cell polyomavirus (MCPyV) DNA in formalin fixed paraffin embedded (FFPE) cutaneous biopsies 335
Tattoo-Associated Skin Reaction: The Importance of an Early Diagnosis and Proper Treatment 333
Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations. 329
BRAF/NRAS Mutation Frequencies among Primary Tumors and Metastases in Patients with Melanoma 326
Hapten-Specific TH17 Cells in the Peripheral Blood of β-Lactam-Induced AGEP. 324
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 313
Multiparametric analysis of cell-free DNA in melanoma patients. 309
The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600 305
Discrepant alterations in main candidate genes among multiple primary melanomas 302
Transient Receptor Potential Vanilloid 4 (TRPV4) is Down-Regulated in Keratinocytes in Human Non-Melanoma Skin Cancer. 301
Targeting the PD1/PD-L1 axis in melanoma: Biological rationale, clinical challenges and opportunities 299
Integrated Akt/PKB Signaling in Immunomodulation and Its Potential Role in Cancer Immunotherapy 296
Expression of protease-activated receptor-1 and-2 in orofacial granulomatosis 293
Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations. 292
Interactive atlas of dermatoscopy. Dermoscopy: a tutorial. 291
Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma 283
Efficacy of treatment with oral alitretinoin in patient suffering from lichen simplex chronicus and severe atopic dermatitis of hands 283
Impact of low-thermal-injury devices on margin status in laryngeal cancer. An experimental ex vivo study 282
A Critical Reappraisal of Primary and Recurrent Advanced Laryngeal Cancer Staging 280
KIT genetic alterations in anorectal melanomas. 276
Acetaminophen, via its reactive metabolite N-acetyl-p-benzo-quinoneimine and transient receptor potential ankyrin-1 stimulation, causes neurogenic inflammation in the airways and other tissues in rodents. 271
Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas. 265
Molecular and computational diagnostic approach identifies FOXP3, ICOS, CD52 and CASP1 as the most informative biomarkers in acute graft versus host disease. 265
SPECIFIC IMMUNE THERAPY-RELATED CUTANEOUS b-CELL PSEUDOLYMPHOMA WITH FOLLOWING DISSEMINATION 263
Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases. 263
Tissue prognostic biomarkers in primary cutaneous melanoma. 262
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma. 261
Baseline β-catenin, programmed death-ligand 1 expression and tumour-infiltrating lymphocytes predict response and poor prognosis in BRAF inhibitor-treated melanoma patients 258
Increase in FOXP3(+) Regulatory T Cells in GVHD Skin Biopsies Is Associated with Lower Disease Severity and Treatment Response 257
CYTOTOXIC/NATURAL KILLER CELL CUTANEOUS LYMPHOMAS: REPORT OF THE E.O.R.T.C. CUTANEOUS LYMPHOMA TASK FORCE WORKSHOP. 257
Nras in melanoma: Targeting the undruggable target 253
Expression and prognostic significance of matrix metalloproteinases and their tissue inhibitors in primary neuroendocrine carcinoma of the skin. 252
Immunomodulating property of MAPK inhibitors: From translational knowledge to clinical implementation 252
X-linked ichthyosis in a patient with congenital hypothyroidism 249
Application of a filtration and isolation by size technique for the detection of circulating tumor cells in cutaneous melanoma. 249
The burden of cutaneous adnexal carcinomas and the risk of associated squamous cell carcinoma: a population-based study 240
Cutaneous leiomyosarcoma: a clinical, dermoscopic, pathologic case study 231
The 2018 World Health Organization classification of cutaneous, mucosal, and uveal melanoma detailed analysis of 9 distinct subtypes defined by their evolutionary pathway 225
Atypical Spitz tumors in patients younger than 18 years 221
A study on the placenta in stillbirth: an evaluation of molecular alterations through next generation sequencing 220
Recognition of Cutaneous Melanoma on Digitized Histopathological Slides via Artificial Intelligence Algorithm 220
Thrombophilic status may predict prognosis in patients with metastatic BRAFV600-mutated melanoma who are receiving BRAF inhibitors. 218
Allele specific Taqman–based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients. 217
AKT-ions with a TWIST between EMT and MET 217
Nevi and Breslow thickness in melanoma: sex differences? 216
Eosinophilic dermatosis of hematologic malignancy: A retrospective cohort of 37 patients from an Italian center 215
Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma 213
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma 213
MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortium 210
EXPRESSION OF THE RETINOBLASTOMA-RELATED GENE RB2/P130 CORRELATES WITH CLINICAL OUTCOME IN ENDOMETRIAL CANCER 209
Fluorescence-advanced videodermatoscopy: A promising and potential technique for the in vivo evaluation of vitiligo 207
Non-linear laser imaging of skin lesions 206
EPITHELIAL OVARIAN TUMORS IN THE REPRODUCTIVE AGE GROUP: AGE IS NOT AN INDEPENDENT PROGNOSTIC FACTOR 205
Formalin safety in pathology laboratory and innovative monitoring for airborne formaldehyde exposure 204
An updated European Organisation for Research and Treatment of Cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for melanoma 204
ANGIOKERATOMA CORPORIS DIFFUSUM (ANDERSON FABRY'S DISEASE): A CASE REPORT 201
A blue-LED-based device for selective photocoagulation of superficial abrasions: theoretical modeling and in vivo validation 201
Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors. 201
Evidence for differential expression of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma. 201
Detection of Merkel cell polyomavirus and human papillomavirus DNA in porocarcinoma 201
In-vivo tissue imaging using a compact mobile nonlinear microscope 199
Mutational concordance between primary and metastatic melanoma: A next-generation sequencing approach 199
Clinical and dermoscopic features of lichenoid keratosis: A retrospective case study 198
The impact of histopathologic examination of graft-versus-host disease in the era of reduced-intensity conditioning regimen: a study from the Gruppo Italiano Trapianto di Midollo Osseo 197
Primary Orbital Synovial Sarcoma Mimicking a Periocular Cyst 196
Trpa1 expression in synovial sarcoma may support neural origin 196
Characterization of regulatory T cells in patients with dermatomyositis. 195
Bullous eruption in a patient with B-cell chronic lymphocytic leukemia: a diagnostic challenge 195
A ribonuclease protection assay-based approach for analysis of angiogenic gene expression in archival tissues. 194
Kaposi Sarcoma in a patient treated with Ruxolitinib 194
A further case of subacute prurigo-like linear IgA bullous dermatosis: growing evidence of a new subset. 194
Analysis of protease-activated receptor-1 and -2 in human scar formation. 192
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors 191
GIANT PELVIC RETROPERITONEAL LIPOSARCOMA 190
Atypical Spitzoid melanocytic tumors: a morphological,mutational, and FISH analysis 190
BRAF Mutated and Morphologically Spitzoid Tumors, a Subgroup of Melanocytic Neoplasms Difficult to Distinguish From True Spitz Neoplasms 189
PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux 189
An Upgrade of Apparatus and Measurement Systems for Generation of Gaseous Formaldehyde: A Review 187
Preoperative evaluation of tumor ploidy in endometrial cancer: an accurate tool to identify patients at risk for extrauterine disease and recurrence. 187
CUTANEOUS MELANOMA HISTOLOGICALLY ASSOCIATED WITH A NEVUS AND MELANOMA DE NOVO HAVE A DIFFERENT PROFILE OF RISK. RESULTS FROM A CASE-CONTROL STUDY 187
Circulating Tumor Cells Detection and Counting in Uveal Melanomas by a Filtration-Based Method 187
Expression of cyclo-oxygenase-2 in macrophages associated with cutaneous melanoma at different stages of progression 187
Polymorphisms of estrogen receptors: risk factors for invasive melanoma - a prospective study. 187
Diagnostic significance of blue hue in dermoscopy of melanocytic lesions: A dermoscopic-pathologic study. 186
Ntrk gene fusion detection in atypical spitz tumors 185
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients 184
Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature 184
Multimodal fiber probe spectroscopy for tissue diagnostics applications: a combined Raman-fluorescence approachBiomedical Vibrational Spectroscopy VI: Advances in Research and Industry 183
A reappraisal of the histopathologic criteria for the diagnosis of cutaneous allogeneic acute graft-vs-host disease 183
Melanoma of the penis: a clinical dermoscopic case study. 183
Combined non-linear laser imaging (two-photon excitation fluorescence microscopy, fluorescence lifetime imaging microscopy, multispectral multiphoton microscopy) in cutaneous tumours: first experiences 183
Atypical Spitz tumours: an epidemiological, clinical and dermoscopic multicentre study with 16 years of follow-up 182
A particularly bothersome umbilical nodule. 182
Clinical and Dermoscopic Features of Vulvar Melanosis over the Last 20 Years 182
Acral lentiginous melanoma treated with topical imiquimod cream: possible cooperation between drug and tumour cells. 182
Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma. 181
Totale 24.072
Categoria #
all - tutte 197.842
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 197.842


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.720 113 231 230 99 134 140 116 197 159 120 445 736
2022/20236.953 682 1.306 251 515 576 1.318 825 357 722 61 184 156
2023/20243.012 111 318 452 151 156 375 179 557 119 241 201 152
2024/202517.280 676 1.923 1.174 2.651 4.647 1.980 336 929 1.004 509 718 733
2025/202622.748 2.143 3.051 1.978 1.760 2.206 859 2.505 1.201 1.499 1.514 802 3.230
2026/2027427 427 0 0 0 0 0 0 0 0 0 0 0
Totale 71.602